News and information about basic science that may lead researchers to develop a cure for HIV – studies of the latent viral reservoir, shock and kill approaches, gene therapies, immune modulators therapeutic vaccines, broadly neutralizing antibodies and so on.

The search for a cure: latest news

The search for a cure resources

The search for a cure features

The search for a cure news from aidsmap

More news

The search for a cure news selected from other sources

  • Trump quietly shuts down HIV cure research to appease the religious right

    Scientists are speaking out against a directive by the Trump administration that has shut down research into a cure for HIV. A scientist who was supposed to supply mice that have been modified with human fetal tissue for an HIV study emailed researchers that the Department of Health and Human Services (HHS) “has directed me to discontinue procuring fetal tissue.”

    12 December 2018 | LGBTQ Nation
  • UCSF HIV Lab Planning to Close

    The facility is the second to have a federal contract involving fetal tissue research cancelled.

    06 December 2018 | The Scientist
  • Open letter from Chinese HIV professionals on human genome editing

    As Chinese professionals engaged in HIV research and prevention, we strongly oppose genome editing on healthy human germline cells and embryos for reproductive purposes and HIV prevention.

    05 December 2018 | The Lancet
  • Needles in a haystack: the quest for bnAbs

    HIV induces antibody responses in infected individuals, but only a few of these individuals manage to produce antibodies that are capable of viral neutralization—and even fewer produce antibodies that can neutralize different strains of HIV.

    01 December 2018 | Nature
  • Liver transplant from HIV+ living donor to negative recipient: the unanswered questions

    A lifesaving partial liver transplant from an HIV-infected mother to her uninfected child – the first of its kind – was conducted last year at the University of the Witwatersrand’s Donald Gordon Medical Centre in Johannesburg. More than a year later, both mother and child are doing well. But the crucial question of the child’s HIV infection status remains unanswered. And we don’t expect to have a definitive answer any time soon.

    29 November 2018 | The Conversation
  • Gene-Edited Twins in China Still Face Risk of HIV Infection

    Certain relatively uncommon strains of HIV would be able to enter their cells if the girls were to come in contact with contaminated tissues or fluids, said Robin Shattock, chairman of mucosal infection and immunity at the U.K.’s Imperial College London.

    28 November 2018 | Bloomberg
  • Patients with rare natural ability to suppress HIV shed light on potential functional cure

    Researchers at Johns Hopkins have identified two patients with HIV whose immune cells behave differently than others with the virus and actually appear to help control viral load even years after infection. Moreover, both patients carry large amounts of virus in infected cells, but show no viral load in blood tests. While based on small numbers, the data suggest that long-term viral remission might be possible for more people.

    27 November 2018 | Johns Hopkins University School of Medicine
  • HIV Researchers Slam The Scientist Who Made Genetically Engineered Babies

    HIV researchers are incensed that the first reported use of gene editing in human embryos was aimed at conferring HIV immunity, criticizing the move as reckless and unnecessary.

    27 November 2018 | Buzzfeed
  • Persistent HIV infection works a lot like cancer, study shows

    The Fred Hutch study points strongly in one direction: “We think that nearly all of these cells carrying HIV — greater than 99.9 percent — were generated via proliferation,” said Schiffer, a physician who also uses computers to model HIV-eradication strategies.

    20 November 2018 | Fred Hutch News Service
  • HIV latency differs across tissues in the body

    Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical Center and the University of California, San Francisco, and colleagues.

    16 November 2018 | EurekAlert (press release)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.